CD19 CAR T Cells in Patients With Resistant or Refractory CD19+ Acute Lymphoblastic Leukemia

Clinical trial NCT02975687 · COMPLETED

Trial details

NCT number: NCT02975687
Sponsor: Institute of Hematology & Blood Diseases Hospital, China
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Acute Lymphoblastic Leukemia, Adult B-Cell Acute Lymphoblastic Leukaemia Recurrent

Start date: 2016-11-01
Primary completion: 2018-12-01
Enrollment: 20

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.